These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 36159847)
1. Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency. Drago E; Garbarino F; Signa S; Grossi A; Schena F; Penco F; Santori E; Candotti F; Boztug K; Volpi S; Gattorno M; Caorsi R Front Immunol; 2022; 13():937108. PubMed ID: 36159847 [TBL] [Abstract][Full Text] [Related]
2. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency. Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A Front Immunol; 2022; 13():910021. PubMed ID: 36248833 [TBL] [Abstract][Full Text] [Related]
3. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2. Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544 [TBL] [Abstract][Full Text] [Related]
4. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review. Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845 [TBL] [Abstract][Full Text] [Related]
5. Monogenic polyarteritis: the lesson of ADA2 deficiency. Caorsi R; Penco F; Schena F; Gattorno M Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179 [TBL] [Abstract][Full Text] [Related]
6. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment. Pinto B; Deo P; Sharma S; Syal A; Sharma A Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889 [TBL] [Abstract][Full Text] [Related]
7. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α. Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist. Pilania RK; Banday AZ; Sharma S; Kumrah R; Joshi V; Loganathan S; Dhaliwal M; Jindal AK; Vignesh P; Suri D; Rawat A; Singh S Front Immunol; 2022; 13():869570. PubMed ID: 35592317 [TBL] [Abstract][Full Text] [Related]
9. A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report. Lucane Z; Davidsone Z; Micule I; Auzenbaha M; Kurjane N Pediatr Rheumatol Online J; 2022 Dec; 20(1):118. PubMed ID: 36528591 [TBL] [Abstract][Full Text] [Related]
10. Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort. Andriessen MVE; Legger GE; Bredius RGM; van Gijn ME; Hak AE; Muller PCEH; Kamphuis S; Klouwer FCC; Kuijpers TW; Leavis HL; Nierkens S; Rutgers A; van der Veken LT; van Well GTJ; Mulders-Manders CM; van Montfrans JM J Clin Immunol; 2023 Oct; 43(7):1581-1596. PubMed ID: 37277582 [TBL] [Abstract][Full Text] [Related]
11. Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient. Zhang X; Wang J; Huang X; Zhu Y; Zhu Y; Tang L; Cai H; Fang X; Huang L Front Immunol; 2023; 14():1099468. PubMed ID: 36825017 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of adenosine deaminase 2 (DADA2): Review. Sharma V; Deo P; Sharma A Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410 [TBL] [Abstract][Full Text] [Related]
13. Clinical presentation of children with Deficiency of Adenosine deaminase 2: A case series. Kisla Ekinci RM; Anlas O; Ozalp O Eur J Med Genet; 2022 Aug; 65(8):104555. PubMed ID: 35777620 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment. Grim A; Veiga KR; Saad N Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195 [TBL] [Abstract][Full Text] [Related]
15. Case Report: Interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2: are all heterozygous born equals? Pulvirenti F; Cinicola BL; Ferrari S; Guadagnolo D; Sculco E; Capponi M; Loffredo L; Sciannamea M; Insalaco A; Quinti I; De Benedetti F; Zicari AM Front Immunol; 2023; 14():1156689. PubMed ID: 37207212 [TBL] [Abstract][Full Text] [Related]
16. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451 [TBL] [Abstract][Full Text] [Related]
17. TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2). Deuitch NT; Yang D; Lee PY; Yu X; Moura NS; Schnappauf O; Ombrello AK; Stone D; Kuehn HS; Rosenzweig SD; Hoffmann P; Cudrici C; Levy DM; Kessler E; Soep JB; Hay AD; Dalrymple A; Zhang Y; Sun L; Zhang Q; Tang X; Wu Y; Rao K; Li H; Luo H; Zhang Y; Burnham JM; Boehm M; Barron K; Kastner DL; Aksentijevich I; Zhou Q J Allergy Clin Immunol; 2022 May; 149(5):1812-1816.e6. PubMed ID: 34780847 [TBL] [Abstract][Full Text] [Related]
18. Importance of the determination of enzymatic activity in the diagnosis of deficiency of adenosine deaminase 2 (DADA2). Abbasi A; Batllori M; Gil-Sáez FJ; Rodríguez-Pintó I; Antón López J; Iglesias Jímenez E Med Clin (Barc); 2022 Sep; 159(6):283-286. PubMed ID: 35241284 [TBL] [Abstract][Full Text] [Related]
19. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Rama M; Duflos C; Melki I; Bessis D; Bonhomme A; Martin H; Doummar D; Valence S; Rodriguez D; Carme E; Genevieve D; Heimdal K; Insalaco A; Franck N; Queyrel-Moranne V; Tieulie N; London J; Uettwiller F; Georgin-Lavialle S; Belot A; Koné-Paut I; Hentgen V; Boursier G; Touitou I; Sarrabay G Eur J Hum Genet; 2018 Jul; 26(7):960-971. PubMed ID: 29681619 [TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic lymphohistiocytosis secondary to virus infection and followed by lupus nephritis recurrence in a renal transplantation pediatric recipient: a case report. Li J; Gao C; Zhu X; Yang D; Mao W; Yao H; Deng M; Tan L; Dai H; Xie X; Peng L; Peng F BMC Nephrol; 2023 Jul; 24(1):200. PubMed ID: 37400798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]